Nonadherence, Clinic Inertia, and Ineffective Adherence in Antihypertensive Treatment in Latin America

Area of Science:

• Cardiology
• Public Health
• Health Services Research

Background:

• Arterial hypertension (HTN) is a leading modifiable risk factor for cardiovascular diseases in Latin America.
• Inadequate control rates are driven by widespread nonadherence to antihypertensive treatment (14-94%) and clinical inertia.
• The combination of nonadherence and clinical inertia creates a cycle of poorly controlled HTN, increasing morbidity, mortality, and economic burden.

Purpose of the Study:

• To review the scope of nonadherence and clinical inertia in hypertension management in Latin America.
• To examine the socioeconomic impacts of these challenges.
• To identify potential interventions for mitigating their effects on public health.

Main Methods:

• This is a review article examining existing literature and data on hypertension management in Latin America.
• The review synthesizes information on nonadherence rates, clinical inertia definitions and prevalence, and their consequences.
• It also explores proposed and implemented intervention strategies.

Main Results:

• Nonadherence and clinical inertia are significant barriers to effective hypertension control in the region.
• "Ineffective adherence," where patients adhere but do not achieve goals, is a major concern, often due to clinical inertia.
• These factors contribute to increased cardiovascular events and healthcare costs.

Conclusions:

• Comprehensive strategies are essential for improving HTN control in Latin America.
• Recommended interventions include patient-centered approaches, enhanced provider education, healthcare system reforms, and team-based care models.
• Implementing these strategies can reduce the burden of uncontrolled hypertension and its associated cardiovascular risks.